Clinical Trial

Radiofrequency and Cryoablation of the Posterior Wall of the Left Atrium

Recruiting
View on ClinicalTrials.gov →
Summary
Atrial fibrillation (AF) is the cause of 20% of strokes, and the risk of stroke in a person suffering from this arrhythmia increases by 5 times. Ischemic stroke in patients with AF is often fatal and, compared with stroke of other etiology, leads to the most pronounced disability and more often recurs. Accordingly, the risk of death in patients with AF-related stroke is 2 times higher, and treatment costs increase 1.5 times. The main interventional method of treating AF, available in most medical institutions, is the use of radio frequency and/or cryoenergy to eliminate destructive damage to the left atrium (LA). The aim of this study is to compare two different interventional methods and identify predictors of recurrence in patients with persistent and long-term AF.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2024-02-02; most recent amendment 2026-07-17.
Trial Details
NCT Number NCT06253000
Lead Sponsor Bakulev Scientific Center of Cardiovascular Surgery
Conditions Stroke, Acute Cerebrovascular Accident, Transient Ischemic Attack, Death, Atrial Fibrillation Recurrent
Enrollment 158 participants
Start Date 2023-06-10
Primary Completion 2026-12-30 (estimated)
Study Completion 2026-12-30 (estimated)
Updated on ClinicalTrials.gov 2026-07-20